Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Bioorganic & Medicinal Chemistry Letters|August 7, 2010
Two distinct classes of novel pyrazolinecarboxamides as potent cannabinoid CB1 receptor agonistsJos H M Lange, Amos Attali, Martina A W van der Neut, et al.Bioorganic & Medicinal Chemistry Letters|September 6, 2005
Novel 3,4-diarylpyrazolines as potent cannabinoid CB1 receptor antagonists with lower lipophilicityJos H M Lange, Herman H van Stuivenberg, Willem Veerman, et al.European Journal of Medicinal Chemistry|September 2, 2011
Biophysical and physicochemical methods differentiate highly ligand-efficient human D-amino acid oxidase inhibitorsJos H M Lange, Jennifer Venhorst, Maria J P van Dongen, et al.Bioorganic & Medicinal Chemistry Letters|December 25, 2009
Synthesis and SAR of novel imidazoles as potent and selective cannabinoid CB2 receptor antagonists with high binding efficienciesJos H M Lange, Martina A W van der Neut, Henri C Wals, et al.Journal of Medicinal Chemistry|March 18, 2005
Bioisosteric replacements of the pyrazole moiety of rimonabant: synthesis, biological properties, and molecular modeling investigations of thiazoles, triazoles, and imidazoles as potent and selective CB1 cannabinoid receptor antagonistsJos H M Lange, Herman H van Stuivenberg, Hein K A C Coolen, et al.The Journal of Biological Chemistry|November 8, 2014
Allosteric inhibition of the neuropeptidase neurolysinChristina S Hines, Kallol Ray, Jack J Schmidt, et al.Bioorganic & Medicinal Chemistry Letters|February 16, 2016
Optimization of N'-(arylsulfonyl)pyrazoline-1-carboxamidines by exploiting a novel interaction site in the 5-HT6 antagonistic binding pocketArnold van Loevezijn, Jennifer Venhorst, Wouter I Iwema Bakker, et al.Journal of Medicinal Chemistry|January 23, 2004
Synthesis, biological properties, and molecular modeling investigations of novel 3,4-diarylpyrazolines as potent and selective CB(1) cannabinoid receptor antagonistsJos H M Lange, Hein K A C Coolen, Herman H van Stuivenberg, et al.Pageof 2